150 related articles for article (PubMed ID: 30481371)
1. Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.
Berger ER; Bilimoria KY; Kinnier CV; Minami CA; Bethke KP; Hansen NM; Merkow RP; Winchester DP; Yang AD
J Surg Oncol; 2019 Jan; 119(1):101-108. PubMed ID: 30481371
[TBL] [Abstract][Full Text] [Related]
2. Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.
Kinnier CV; Paruch JL; Dahlke AR; Wayne JD; Benson AB; Winchester DP; Bilimoria KY
Ann Surg; 2016 Feb; 263(2):392-8. PubMed ID: 26488806
[TBL] [Abstract][Full Text] [Related]
3. The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.
Yen TWF; Li J; Sparapani RA; Laud PW; Nattinger AB
Medicine (Baltimore); 2016 Aug; 95(31):e4392. PubMed ID: 27495053
[TBL] [Abstract][Full Text] [Related]
4. Application of automated image analysis reduces the workload of manual screening of sentinel lymph node biopsies in breast cancer.
Holten-Rossing H; Talman MM; Jylling AMB; Laenkholm AV; Kristensson M; Vainer B
Histopathology; 2017 Dec; 71(6):866-873. PubMed ID: 28677240
[TBL] [Abstract][Full Text] [Related]
5. Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
Percy DB; Pao JS; McKevitt E; Dingee C; Kuusk U; Warburton R
J Surg Oncol; 2018 Jun; 117(7):1487-1492. PubMed ID: 29484663
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: Findings likely to change treatment decisions.
Karanlik H; Ozgur I; Kilic B; Fathalizadeh A; Sanli Y; Onder S; Saip P; Sen F; Gulluoglu BM
J Surg Oncol; 2016 Dec; 114(7):796-802. PubMed ID: 27778360
[TBL] [Abstract][Full Text] [Related]
7. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
8. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
9. Staging breast cancer by sentinel lymph node biopsy: Do patients with a single negative sentinel node (N=1) experience worse outcomes than those with multiple negative sentinel nodes (N>1)?
Wilkerson A; Averbook B; Joseph N; Sharpe S; Li B
Surg Oncol; 2018 Sep; 27(3):327-332. PubMed ID: 30217285
[TBL] [Abstract][Full Text] [Related]
10. Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
Roos MM; van Steenhoven JEC; Aalders KC; Schreuder K; Burgmans JPJ; Siesling S; Elias S; van Dalen T
Ann Surg Oncol; 2019 Feb; 26(2):372-378. PubMed ID: 30387028
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer section analysis correlates with sentinel lymph node biopsies: Precision and topographic anatomy.
Karampelias V; Koukouras D; Tzorakoleftherakis E; Mariolis-Sapsakos T; Chrysikos D
Breast Dis; 2019; 38(1):1-5. PubMed ID: 30829609
[TBL] [Abstract][Full Text] [Related]
12. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
13. Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.
Kuemmel S; Holtschmidt J; Gerber B; Von der Assen A; Heil J; Thill M; Krug D; Schem C; Denkert C; Lubitz J; Blohmer JU; Reinisch M; Hötzeldt M; Seither F; Nekljudova V; Schwidde I; Uhrhan K; Von Minckwitz G; Rezai M; Mulowski J; Loibl S; Kuehn T
J Clin Oncol; 2019 Jun; 37(17):1490-1498. PubMed ID: 31042410
[TBL] [Abstract][Full Text] [Related]
14. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer.
Bercow AS; Rauh-Hain JA; Melamed A; Mazina V; Growdon WB; Del Carmen MG; Goodman A; Bouberhan S; Randall T; Sisodia R; Bregar A; Eisenhauer EL; Minami C; Molina G
Gynecol Oncol; 2023 Feb; 169():47-54. PubMed ID: 36508758
[TBL] [Abstract][Full Text] [Related]
15. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
[TBL] [Abstract][Full Text] [Related]
16. Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study.
Garcia-Tejedor A; Falo C; Quetglas C; Soler T; Marqueta B; Ortega R; Gil-Gil M; Pernas S; Fernandez-Montolí E; Pla MJ; Guma A; Bajen M; Benitez A; Eraso A; Campos M; Petit A; Ponce J
Int J Surg; 2017 Mar; 39():141-147. PubMed ID: 28153783
[TBL] [Abstract][Full Text] [Related]
17. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed?
Baker JL; Muhsen S; Zabor EC; Stempel M; Gemignani ML
Ann Surg Oncol; 2019 Feb; 26(2):336-342. PubMed ID: 30506175
[TBL] [Abstract][Full Text] [Related]
18. Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study.
Zhang L; Huang Y; Yang C; Zhu T; Lin Y; Gao H; Yang M; Cheng M; Wang K
World J Surg Oncol; 2018 Jun; 16(1):112. PubMed ID: 29914538
[TBL] [Abstract][Full Text] [Related]
19. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Laws A; Hughes ME; Hu J; Barry WT; Dominici L; Nakhlis F; Barbie T; Duggan M; Weiss A; Rhei E; Carter K; Nimbkar S; Schnitt SJ; King TA
Ann Surg Oncol; 2019 Nov; 26(12):3846-3855. PubMed ID: 31222687
[TBL] [Abstract][Full Text] [Related]
20. [Discussion on the indications of internal mammary sentinel lymph node biopsy in breast cancer in the era of precision medicine].
Wang YS; Zhao RR; Liu YB; Chen P; Zhao T; Sun X; Wang CJ; Zhang ZP; Shi ZQ; Qiu PF
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):251-256. PubMed ID: 31014049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
